Cleared Traditional

K832423 - ENVISION G21 I/A ENPAK

K832423 is an FDA 510(k) clearance for ENVISION G21 I/A ENPAK, manufactured by Envision, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K832423 · Envision, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1983
Decision
52d
Days
Class 2
Risk

K832423 is an FDA 510(k) clearance for the ENVISION G21 I/A ENPAK. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Envision, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 12, 1983 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Envision, Inc. devices

FDA 510(k) Submission Details - K832423

510(k) Number K832423 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 1983
Decision Date September 12, 1983
Days to Decision 52 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 110d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 198
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K832423.
DISPOSABLE I/A HANDPIECE
K833784 · CooperVision, Inc. · Feb 1984
IRRIGATION ASPIRATION KIT
K833405 · American Medical Optics · Jan 1984
STORZ EXTRA
K833064 · Storz Instrument Co. · Jan 1984
EPSILON ULTRASONIC TIP
K831836 · CooperVision, Inc. · Jun 1983
ULTRAKIT
K831172 · Staar Surgical Co. · Jun 1983
IV STAND
K830474 · Teknar, Inc. · Apr 1983